By Leslie Carol Botha
(NaturalNews) Immunologist Charlotte Haug, MD PhD, MSc and Editor-in-Chief, Tidsskrift for Den norske legeforening (The Journal of the Norwegian Medical Association) raises an interesting question that has yet to be considered by the FDA, CDC or the medical community. What happens if other strains of HPV replace strains 16 or 18 after vaccination by Gardasil or Cervarix? If the vaccines are effective will the replacement viruses cause less disease or more disease?
SANE Vax Inc. is demanding Gardasil and Cervarix be taken off the market until these questions are answered in an independent study on HPV vaccine safety and efficacy.
Dr. Haug presented ‘To vaccinate or not – a different point of view’ at the 1st Nordic Gynecologic Meeting on HPV vaccination in March 2010 where she raised these questions. She stated that “Nature never leaves a void” and cited two studies that raise concern about viral replacement:
Alaska native children are experiencing replacement invasive pneumococcal disease just four years after vaccination (JAMA 2007)(1)
HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country (PubMed.gov)(2) Murillo et al 2009 revealed in this study that:
– Age-specific HPV type prevalence revealed significant differences
– Multiple high-risk infections appeared in 17% of the cases and represent a chance of replacement
– Highlight the role of HPVs other than 16/18 that will affect potential vaccine impact
Multiple high-risk infections appeared in 16.6% of cases and represent a chance of replacement. Age-specific HPV prevalence and multiple high-risk infections might influence vaccine impact. Both factors highlight the role of HPVs other than 16/18, which should be considered in cost-effectiveness analyses for potential vaccine impact.
A graph included in the above study – http://www.ncbi.nlm.nih.gov/pmc/art… – clearly shows that HPV 16 & 18 are not even prevalent in Colombian women until their mid-20s – long after vaccine efficacy has worn off if a girl is administered Gardasil or Cervarix in her adolescent years.
What are these vaccines doing? What are they effective against? And why are they on the market before these questions are answered?
SANE Vax, Inc. wants to remind medical consumers that viral replacement is not a new concept. The medical community is currently looking for ways to combat super-bacteria such as MRSA – (Methicillin-resistant Staphylococcus aureus) infection caused by a strain of staph bacteria that’s become resistant to the antibiotics commonly used to treat ordinary staph infections.(3)
When antibiotics were invented, no one understood bacterial and viral mechanisms of action; they have only one purpose – and that is to survive. Staph and strep bacteria mutated to survive in the suppressive environment created by the use, and abuse, of antibiotics. These ‘super-strains’ now pose a substantial risk to human survival in those exposed. Will the same thing happen as various strains of HPV in vaccines are suppressed?
The Colombian study raises another issue that needs to be addressed and that is whether HPV 16 & 18 are the dominant viral strains in the targeted demographic.
A May 2008 study on high-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women presented at the Second Annual International African-Caribbean Cancer Consortium Conference cited that:
The most important finding was that unlike the genotype distribution patterns seen in North America, Europe and some parts of Asia [11,12] HPV types 16 and 18 were not the most common high-risk genotypes. In our population, HPV types 45 and 58 accounted for 40.5% of the genotypes. Other groups, e.g. Trinidad and Tobago, Cuba and parts of Africa [13-18], have also reported different distributions of genotypes indicating that types 16 and 18 were not predominant in these populations. The recently developed prophylactic vaccines may therefore not be efficacious in our and similar populations.(4)
Why is Gardasil marketed globally through the Gardasil Access Program when HPV 16 & 18 may not even be prevalent amongst the targeted populations?(5)
The GARDASIL Access Program is pleased to announce that, following the November 2010 Advisory Board meeting, three new applicants were recommended for participation in the program. Since inception of the program, organizations and institutions in Bhutan, Bolivia, Cambodia, Cameroon, Georgia, Ghana, Haiti, Honduras, India, Kenya, Kiribati, Lesotho, Moldova, Nepal, Nicaragua, Nigeria, Papua New Guinea, Tanzania, Uganda, and Uzbekistan have been approved to receive more than 1 million doses of GARDASIL to gain operational experience in the design and implementation of HPV vaccination projects in their countries.
Interesting to note that Jamaica is not listed as one of the eligible countries for the Access Program? Is this because of the study?(6)
The conclusion of yet another study published in 2006, Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia states that infections with multiple HPV types seem to act synergistically in cervical carcinogenesis.(7)
Perhaps this is why the Vaccine Adverse Reaction System (VAERS) is beginning to report numerous cases of abnormal pap smears, genital warts, HPV infections and even cervical cancer post-HPV vaccination:
– 376 abnormal pap smears post HPV vaccination
– 108 reports of anogenital warts found after HPV vaccination
– 224 reports of papillomavirus infections found after HPV vaccination
– 41 reports of cervical cancer after HPV vaccination
Clearly there is a problem with the HPV vaccines – and it is the uninformed medical consumers who will suffer. Clearly, not enough studies have been conducted on the safety and efficacy of the HPV vaccines in targeting only two carcinogenic strains of HPV – that might not even be prevalent in many populations.
According to the CDC, “While there are well-established cancer registries in the United States, it will take decades before the impact of vaccine on cervical cancer is observed. More proximal measures of vaccine impact include outcomes such as prevalence of HPV vaccine types, incidence of cervical pre-cancers and genital warts.”(8)
SANE Vax, Inc. believes that there is no evidence to support the hypothesis that Gardasil or Cervarix effectively protects against cervical cancer. Indeed, the May 2006 FDA VRBPAC supports this conclusion by stating that if a woman is previously exposed to vaccine relevant HPV and is vaccinated anyway, her chances of getting cervical cancer increase 44.6% post Gardasil and 32.5% post Cervarix.(9)
Source:
1. Invasive Pneumococcal Caused by Nonvaccine Serotypes Among Alaska Native Children with High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage, JAMA. 2007;297(16):1784-1792. doi: 10.1001/jama.297.16.1784 http://jama.ama-assn.org/content/29…
2. HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country, Infect Dis Obstet Gynecol. 2009;2009:653598. Epub 2009 Dec 20, http://www.ncbi.nlm.nih.gov/pubmed/…
3. MRSA Definition, Mayo Clinic, http://www.mayoclinic.com/health/mr…
4. High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women, Proceedings from the Second Annual International African-Caribbean Cancer Consortium Conference; Miami, FL USA 12–13 May 2008, http://www.ncbi.nlm.nih.gov/pmc/art…
5. Gardasil Access Program, http://gardasil-access-program.org/
6. Gardasil Access Program List of Eligible Countries, http://gardasil-access program.org/section/145
7. Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia, Cancer Epidemiology Biomarkers and Prevention, May 2006, http://cebp.aacrjournals.org/conten…
8. Post-licensure monitoring of HPV vaccine in the United States, Centers for Disease Control and Prevention, Vaccine. 2010 Jul 5;28(30):4731-7. Epub 2010 Feb 25, http://www.ncbi.nlm.nih.gov/pubmed/…
9. May 2006 VRBPAC Report, http://www.fda.gov/ohrms/dockets/ac…
An excellent article focusing on unanswered questions regarding the relevant issue of replacement.
The fact that there are unlike genotype distribution patterns in different populations implies that the recently developed HPV vaccines should not automatically be promoted to different populations.
Dr. Sin Hang Lee, a prominent cancer pathologist and HPV testing expert, states: “If a young woman is considering taking an HPV vaccine, it is critical that she knows if she has been exposed to HPV, and if so, what genotype”.
In developed countries we are advised to refrain from vaccination if we are ill, but in many developing countries it is not unusual for inhabitants to suffer from one or more diseases, their immune systems are compromised. There are often poor resources with limited possibility for pre-testing, monitoring and follow-up in these countries. It may well be questioned whether in some circumstances vaccination of these populations is medically irresponsible and unethical .
The numerous cases of abnormal pap smears, genital warts, HPV infections and even cervical cancer post-HPV vaccination, which are referred to in the article, should probably be multiplied by at least ten to get a more realistic picture, as there is gross under-reporting to VAERS.
One reason for this is no doubt the fact that the package insert information gives the contact information for the manufacturer, Merck before that of VAERS:
To report SUSPECTED ADVERSE REACTIONS, contact Merck
Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., at 1-877-
888-4231 or VAERS at 1-800-822-7967 or http://www.vaers.hhs.gov.
The manufacturer has no incentive to take reports seriously with respect to their own products. On the contrary, this is a case of the fox guarding the henhouse.
Replacement is normal phenomenon in virology and yet it is either ignored or toned down by vaccine promoters.
The Norwegian health authorities introduced a controversial mass vaccination Gardasil program for 12 year old girls, no payment being required. Payment for a booster which is planned for girls from 13 – 17 years, was discussed by a specially appointed committee. The pros and cons of the vaccine which were discussed by the committee included the statement: “ The issue of replacement was not considered”.
In addition to replacement, carcinogenicity regarding the actual vaccine ingredients is unknown. In the package insert it is stated:
13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
GARDASIL has not been evaluated for the potential to cause carcinogenicity or genotoxicity.
This appears to be the attitude of vaccine promoters: ignore a possible problem – then it maybe does not exist and therefore it need not be addressed.
HPV vaccines have been misleadingly promoted as “cancer vaccines”. Because it is not known whether they may actually increase the risk of cancer due to possible cancerogenic properties of the ingredients and by replacement, it may be questioned whether the term “cancer vaccines” is indeed appropriate!
.INEFFICACY OF THE HPV VACCINE SEEN BY DOCTOR OF DEEP PERÚ
From its inception until the appearance of cervical carcinoma (UCC), takes on average 25 to 30 years, the research of this vaccine have begun in 2000, it is evident that the scientific efficacy of this new vaccine will be determined the years 2025 – 2030.
HPV not causes definitely the (CCU); at the onset of this disease involves multiple risk factors, including the suspected HPV, but scientificaly is proven by epidemiology and statistics that the sex is what generates this disease .: Mix in 130.000 nuns found not any UCC.
http://www.portalesmedicos.com/publicaciones/articles/1832/1/Epidemiologia-del-carcinoma-del-cuello-uterino.html
To accept that a virus or a bacteria causes a infection disease must unfailingly fulfill the five Koch’s postulate
http://www.xatakaciencia.com/salud/los-postulados-de-koch
1 – The agent must be present in every case of the disease and absent from healthy.
2 – The agent must not appear in other diseases.
3 – The agent to be isolated in pure culture from disease lesions.
4 – The agent of causing disease in a susceptible animal being inoculated.
5 – The agent must again be isolated lesions in experimental animals.
http://es.scribd.com/doc/44558220/MICROBIOLOGIA-1
Consequently, HPV not fulfill not any principle of Koch’s postulate. by not meeting this postulate, that is accepted as dogma in medicine, scientifically we must be ensure that the HPV is not the causative agent to the UCC..
Until August 2012 this vaccine produced only in the United States: 265.640 adverse events ( 264,162 females, 9490 males and 5290 unknow sex); permnent disability 8910( 8890 females, 90 males and 110 unknow sex), 1220 deaths (1011 females, 70 males and 140 unknow sex), abnormal PAP 4930, cervical dysplasia 1970 and cervical cancer 570
http://holyhormones.com/vaccinations/hpv-vaccine/hpv-vaccine-adverse-events-reported-to-vaers-as-of-july-13-2012/
http://therefusers.com/?s=cervarix
The Vaccine efects advers reactions (VAERS) ensures that only complaint between 1% to 10% of the adverse effects produced by this evil vaccine;this figures shown are calculated according to the statements of the VAERS: to 10%.
http://www.noticiero.enkoria.com/2011/diez-menores-que-sufrieron-reaccion-adversa-a-la-vacuna-vph-d
http://www.pop.org/content/merck-researcher-admits-gardasil-guards-against-almost-nothing-985
Dr. Harper, who contributed to the development of the vaccine by Merck, reports that the vaccine was not investigated in children under 15 years and the vaccine given to children under 11 years is a big public experiment.
http://offtheradar.co.nz/vaccines/53-researcher-diane-harper-blasts-gardasil-hpv-marketing.html
The vaccine was approved to give girls uncontaminated with HPV, Dr. Howenstinc ensures that the women are vaccinated with HPV contaminated, have the possibility to acquire a 44.6% CCU
http://www.newswithviews.com / Howenstine/james170.htm.
Merck did not disclose that the vaccine was transgenic, the Sane Vax has discovered, which is transgenic because it has been found that the vaccine is contaminated with DNA recombinant vaccine Gardasil (DNArPVH) and has raised its concerns to the president of the FDA Margaret Hamburg. The FDA replied that the vaccine will not cause any damage transgenic
http://real-agenda.com/2011/09/16/vacuna-gardasil-contaminada-con-adn-recombinante-de-vph/
http://bolsonweb.com.ar/diariobolson/detalle.php?id_noticia=26075
A vaccinated child was ill with rheumatoid arthritis, which is an autoimmune disease. 24 hours after vaccination and found that the aluminum adhered to DNArPVH, two years after vaccination and in autopsy 6 months after death in a New Zeland girl Jazmine Renata which had recibed this deadly vaccines
http://www.mecfsforums.com/index.php?topic=9331.0
Management time to get market approval of a drug the FDA is at least three years, it is a drug for cancer 15 years, but the authorization Merck had only six months and the European Medicines Agency (EMA in English) only 9 months: To introduce the vaccine are using the marketing of fear
http://mujeresenaccion.over-blog.es/article-vph-la-vacuna-del-marketing-del-miedo-67210961.ht http://mujeresenaccion.over-blog.es/article-vph-la-vacuna -of-marketing-of-fear-67210961.ht
HPV is ubiquitous; lives in wild and domestic animals, pollute us from birth, is on the doorknobs, on towels, on nails, on fomites, in gloves and specula of gynecologists,. sexual intercourse is not the only means of contamination.
http://spa.myhealthygood.com/cancer-cervical-vacuna-contra-el-vph/investigadores-descubren-el-v
HPV also lives in the 400 nm outermost of our skin and mucous membranes. ,
If you live in our skin, our immune system produces cellular and humoral immunity is acquired or that our body is self vaccinatinge by PVHs living on our skin and mucous ..
http://www.conganat.org/seap/bibliografia/HPVToday/HPVToday007SEAP.pdf
The PVHs is not distributed uniformly worldwide. It has been found that in Canada HPV 18 only reaches 3%; is more often HPV 31, in my country Peru no studies have determined that HPV types predominate; Gardasil contains 225 mcg. aluminum and Cervarix 500 mcg, that produce the Alzheimer, Parkinson and autism, produce too neurotoxic and immune system disorders (Blaylock 2012) and Polisorbato 80, a powerful contraceptive, that in experimental animals produces sterility, atrophy of the testicles and disturbance organic and funtional of the organs of the reproduction; is carcinogenic and mutagenic; also contains sodium borate considered poison unused in medicinal preparations (NLM)
http://www.telefonica.net/web2/paramahamsa/vacunaninosalerta.html http://detenganlavacuna.wordpress.com/2010/11/09/gardasil-cervarix/
Have been discovered to date 200 types of HPV; HPV is not infectious, contagious; the intercourse is not only that the persons is contaminated
http://quimicaclinicauv.blogspot.com/2006/08/virus-del-papiloma-humano.html http://www-lab.biomedicas.unam.mx/smpv/queeshpv.htm
On 22-11-2010 FDA approved Gardasil for males aged 9 to 26 to prevent warts and cancer to the anus, is overkill
http://real-agenda.com/2011/09/16/vacuna-gardasil-contaminada-con-adn-recombinante-de-vph/
http://salud.aollatino.com/2011/02/02/aprueba-fda-nueva-indicacion-vacuna-tetravalente-vph-eeuu/
For the reasons since from deep Peru Huancayo, I believe that this vaccine is a fraud?, robbery?, swindle?, rough joke?.
The HPV is not scientifically proved for the moment that produce the UCC its effectiveness shall be verified just the years of 2025-2030.
Dr. Godofredo Arauzo
E mail: godo.ara@ gmail.com